15
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Environment: the neglected component of the One Health triad

      discussion
      a
      The Lancet. Planetary Health
      The Author(s). Published by Elsevier Ltd.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The One Health approach was conceptualised as a global public health strategy that encourages interdisciplinary collaboration and communication on health at the human-animal-environmental interface. 1 It is defined by the American Veterinary Medical Association as “the collaborative effort of multiple disciplines—working locally, nationally and globally—to attain optimal health of people, animals, and our environment”. 2 The One Health Approach gained popularity in response to zoonotic public health emergencies such as the outbreaks of severe acute respiratory syndrome, Middle East respiratory syndrome, H1N1 influenza, Ebola, and Zika. One Health is also prominent in several global commitments and political declarations such as the Sustainable Development Goals, the International Health Regulations, the Global Health Security Agenda, the UN Paris Agreement on climate change, and the UN Political Declaration on Antimicrobial Resistance. It forms the basis of the tripartite alliance of WHO, the Food and Agriculture Organization of the United Nations, and the International Organization for Animal Health. One Health consists of the triad of human health, animal health, and the environment, but the latter is often neglected, as evident from its absence or cursory mention in most of the initiatives mentioned. This neglect of the environment was also a key finding of the systematic analysis of One Health Networks (OHNs) reported by Mishal Khan and colleagues in The Lancet Planetary Health. 3 The paper highlights to the funders of OHNs the importance of ensuring the equitable inclusion of the human, animal, and environmental sectors of the triad against a consensus definition of One Health to ensure a return on investment by transparent monitoring and evaluation of explicit One Health outputs, outcomes, and impact that improve the strategic direction, coordination and efficiencies of OHNs, locally, regionally and globally. The environment is the most dynamic and consequently the most confounding sector of the One Health triad as evident from the examples of antibiotic resistance and climate change. Antibiotic resistance has been described as the “quintessential One Health issue” as it exists in all three sectors. The relative roles of the three sectors in the development, transmission, and persistence of antibiotic resistance are, however, poorly understood. 4 Antibiotic resistance is a direct consequence of the selection pressure from warranted and indiscriminate antibiotic use in human and animal health 5 and antibiotic exposure in the environment. Use of antibiotics in animal production systems at sub-therapeutic doses for prolonged periods creates optimal conditions for bacteria to entrench antibiotic resistance genes. These genes are subsequently transferred to human pathogens or commensals via humans, contaminated food, or the environment. Antibiotics used in humans and animals are frequently analogues of each other, which potentially drives the transmission of resistance between humans and animals, and there is growing evidence linking antibiotic consumption in livestock to antibiotic resistance in the clinic.4, 6 The burden of antibiotic resistance is least well understood in the environment. Environmental bacteria, which are quantitatively the most prevalent bacteria, serve as reservoirs of resistance genes that can become incorporated into human and animal pathogens over time. These resistance gene reservoirs are augmented by the influx of resistance genes from livestock and human waste into the environment. They are further augmented by the entry of antibiotic residues from pharmaceutical industries, intensive livestock farming, and hospitals, which disrupt the soil and water microflora in addition to exerting selection pressure for the development of resistance. 4 The environment is subject to variable weather patterns, particularly fluctuations in temperature, humidity, and precipitation (not the least of which is as a result of climate change) that affect bacterial ecosystems, making the environment a vacillating sector in the One Health antibiotic resistance triad. Environmental issues have gained greatest traction in terms of climate change and its adverse effects on the health of humans, animals, and the environment. Climate change compromises the ecological and environmental integrity of living systems 7 by inducing lifecycle changes in pathogens, vectors, and reservoirs; new and emerging diseases of plants and food and domestic and wild animals; trophic cascades; interfering with the synchrony between interacting species in a particular habitat; and modifying or destroying habitats. 8 It has been termed the “threat multiplier” in that it adversely affects infectious diseases, zoonosis, food security, food safety, and local, regional, and global responses to them.7, 8 Aligning One Health with climate change could entrench the environmental sector in the One Health triad. The inextricable links between human, animal, and environmental health necessitate a systems approach to One Health. This approach acknowledges that health and disease occur within complex molecular, biological, ecological, economic, social, policy, and political systems. The approach focuses on understanding the functioning of systems, both individually and collectively, in terms of their dynamic relationships, feedback loops, interactions, and dependencies. 9 The success of OHNs is thus contingent on coordinated, interdisciplinary, transdisciplinary, multidisciplinary, multi-stakeholder, multipronged systems partnerships underpinned by national and international policies that suspend sectoral interests for the advancement of One Health.

          Related collections

          Most cited references6

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Antibiotic resistance is the quintessential One Health issue

          The scale of antimicrobial resistance In May this year, the long-awaited final report from the Review on Antimicrobial Resistance was published. 1 The report estimates that the 700 000 annual deaths currently attributable to infections by drug-resistant pathogens will increase, if unchecked, to 10 million by 2050, running up a bill of US$100 trillion in terms of lost global production between now and then. The reported numbers are somewhat apocalyptic, as they are based on crude projections of current trends and presume the failure of anti-malarial drugs and antiretroviral therapy as well as antibiotics. Nor do they account for the possible entry of new drugs onto the market. There is huge uncertainty associated with the human burden of antimicrobial resistance (AMR) in general and antibiotic resistance in particular (for the purpose of this article the widely used term antimicrobial resistance [AMR] is retained, though the emphasis here is on antibiotic resistance). The precision of the estimates does not really matter much: the point is that the problem is already immense and is growing rapidly. We have been squandering our antibiotic resources for far too long and immediate action is needed on a very large scale if we are to reverse current trends. AMR as a One Health issue It is difficult to imagine an issue that epitomises the principles of One Health more than AMR does. The One Health approach, defined as ‘...the collaborative effort of multiple disciplines – working locally, nationally, and globally – to attain optimal health for people, animals and our environment…’, 2 recognises that the health of people is connected to the health of animals and the environment. AMR has clear links to each of these three domains. The contribution of animal production, both terrestrial livestock and aquaculture, to the global AMR crises is questioned by some on the grounds that we don't see so many animal-associated infections in humans. 3 While this may be true, because of the way that many antibiotics are used in animal production, in sub-therapeutic doses and with long exposure periods, these production systems create ideal conditions for bacteria to fix genes that confer resistance. These genes can subsequently be transmitted to human-adapted pathogens or to human gut microbiota via people, contaminated food or the environment. They also provide ideal conditions for the amplification of genes that may have arisen in people or the environment. The fact that the antibiotics used in human and animal health largely comprise the same or very similar molecules would be expected to drive the transmission of resistance between animals and people, either directly or via the environment. Of the three domains, human health takes the spotlight, with multidrug-resistance genes now highly prevalent in many important and common pathogens like Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus. Quite apart from the many infectious diseases for which we rely on antibiotics to combat, these drugs underpin modern medicine by allowing us to carry out common surgical procedures and treatments that depress the immune system, such as chemotherapy to treat cancer. The global burden of AMR on the population has been estimated, 1,4 and more specific studies have also been carried out; for example, the estimated 214 000 neonatal deaths attributable to resistant sepsis infections globally in 2013; 111 523 occurring in the five countries with the highest numbers of neonatal deaths in the world: India, Pakistan, Nigeria, Democratic Republic of Congo and China. 5 Such estimates of the burden of AMR have not been attempted for livestock or aquaculture, perhaps due to a perceived lower importance. Resistance to antibiotics among mastitis pathogens, for example, is well documented though it is not considered to be an emerging or a progressing problem. 6 Recent estimates of the amount of antibiotics consumed in livestock production conservatively place this at 63 151 tonnes in 2010. 7 The situation is less clear in aquaculture. 8 Although actual figures are currently unavailable, the published estimates of the proportion of antibiotics consumed in animal agriculture—84% (for 36 antibiotics) in China 9 and 70% in USA 10 —suggest global agricultural consumption probably exceeds that of humans. A large part of this use is justified and valid on veterinary grounds, 6 but there is much misuse in the agricultural sector. With such large consumption levels it seems likely that agricultural use contributes significantly to AMR. A recent review suggested that misuse of antimicrobials in animal production is a clear and substantial driver of AMR, 11 and there is a growing body of evidence linking antibiotic consumption in livestock to AMR in the clinic. 12 Many infections in people are endogenous; derived from the human gut flora. An important gap in knowledge relates to the possible extent and mechanisms of transmission of antibiotic resistance genes between the normal gut flora of animals and that of humans. The third One Health pillar, environmental health, including that of crops where antimicrobials are also used in plant protection, 13 is the least well understood in this tangled web of antibiotic gene evolution, transmission and persistence. Environmental bacteria, being quantitatively the most prevalent organisms, serve as sources for AMR genes that can become incorporated, over time, into pathogens of people and animals. This naturally occurring phenomenon is exacerbated by the influx to the environment of AMR genes from livestock and human waste 14 and by the vast quantities of antibiotic residues that enter the environment from the pharmaceutical industry, 15 from intensive livestock farms 16 and from hospitals. 17 Because of this, it has been proposed that these activities represent effective hotspots for the development and spread of AMR genes. 18 The impact of such factors is likely to be more pronounced in developing countries with lax environmental legislation and enforcement. Soil and water microflora play complex and critical roles in ecosystem functions such as the recycling of carbon and nutrients. Disrupting these vital processes by creating an imbalance may threaten planetary health, 19 potentially pushing ecosystems beyond critical environmental thresholds. 20 The relative roles of these three domains in the development, transmission and persistence of AMR genes is poorly understood. A truly One Health approach to dealing with AMR, embracing all three domains, will depend on a sound grasp of the relative importance of each in the evolution of AMR bacteria and genetic determinants, the ways in which they interact, and the transmission routes and mechanisms involved. AMR is also a One World issue As well as being a One Health issue, AMR is a One World issue. The globalisation of the food system, with increasing movement of livestock and agricultural produce, combined with increasing human travel, facilitates the rapid spread and mixing of AMR genes that emerge. A worrying example is the emergence of a plasmid-mediated resistance gene (mcr-1) to colistin, a last-resort antibiotic, identified in people and pigs in China last year. 21 This was followed by its rapid spread across Europe and Canada to the USA, where it has recently been identified. 22 A similar case is the spread of New Delhi metallobeta-lactamase 1 (NDM-1), a transmissible genetic element encoding resistance genes against most known beta-lactam antibiotics, from its point of emergence in New Delhi, India, in 2008. 23 Likened in this regard to carbon emissions, 24 no matter how good a country's programme of antimicrobial stewardship in health and agriculture, they are laid bare to the importation of AMR genes that have emerged and spread from other parts of the world. Such rapid spread of resistance must surely create a disincentive for the pharmaceutical industry, with an eye on profits from high income countries (HICs), to develop new antimicrobials against which AMR genes may be rapidly acquired through abuse in low- and middle-income countries (LMICs). The other factor making AMR a One World issue is that dealing with AMR is central to the long-term economic development of countries and to our global well-being. 1 LMICs face the greatest burden of AMR because of their disease-prone environments, poorer sanitary standards and, for the poorest, much reduced access to effective antibiotics. 5 Poor access to competent veterinary and extension services leaves farmers in LMICs with antibiotics as their only resource to tackle endemic bacterial animal infections. Interventions must be based on an understanding of and respect for the different social and socio-economic contexts in which they are to be implemented. AMR is a global problem calling for global solutions: but the solutions will not be the same in every country, or among different socio-economic groups. Some use antimicrobials too much, some too little and many use them unwisely: understanding patterns of use and incentives for changing these, and exploring alternative options, must underpin any reduction efforts. Increasing recognition of AMR The Review on Antimicrobial Resistance comes at an important time and has no-doubt already been influential in bringing this critical topic into the arena of global public debate among stakeholders who would normally have not paid attention to this problem. The commitment by G7 countries in Berlin in 2015, to promote the AMR agenda, was cemented at this year's G7 Ise-Shima Summit in Japan, at which it was proposed to ‘promote the One Health Approach to tackle cross-cutting issues of AMR in human and animal health, agriculture food and the environment, and take actions involving multiple sectors, such as by integrating collaboration between the responsible ministries, in line with the 2015 WHO Global Action Plan on AMR adopted and relevant resolutions of FAO and OIE.’ 25 In May 2015, the 68th World Health Assembly endorsed a resolution making it mandatory for member countries to align national action plans with the global standard by May 2017, and WHO subsequently published the Global Action Plan on Antimicrobial Resistance 26 to guide Member States in developing their plans. It is expected that a resolution will be adopted at the 71st Session of the United Nations General Assembly in September 2016, which, if effective, could place national governments under pressure to take action towards reducing consumption of antibiotics in both human medicine and agriculture. Call for interdisciplinary research in support of appropriate action Whatever action we take will only be sustainable if it is based on a sound understanding of the relative roles of people, animals and the environment in the emergence, spread and persistence of AMR genes. This is not a problem that HICs will be able to solve alone. The important role that animal agriculture plays in livelihoods in LMICs is unknown or underestimated by many in HICs and needs to be an integral part of the thinking and negotiation if we want to avoid the pitfalls seen in climate negotiations, with LMICs often reluctant to take measures that may compromise their short-term economic development. The One Health science seems to fall short when it comes to understanding the economic forces behind many emerging infectious diseases; there is a further gap to be bridged between the biomedical, environmental and animal sciences, and the social sciences. Integrated approaches to reduce selection pressure and disrupt AMR transmission cycles on a global scale must be sought that are founded not only on sound One Health principles, but also based on economic evidence and on principles of social equity and global access to effective healthcare for people and their animals.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found
            Is Open Access

            The growth and strategic functioning of One Health networks: a systematic analysis

            The recent increase in attention to linkages between human health, animal health, and the state of the environment has resulted in the rapid growth of networks that facilitate collaboration between these sectors. This study ascertained whether duplication of efforts is occurring across networks, which stakeholders are being engaged, and how frequently monitoring and evaluation of investments is being reported.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Animal production and antimicrobial resistance in the clinic.

                Bookmark

                Author and article information

                Contributors
                Journal
                Lancet Planet Health
                Lancet Planet Health
                The Lancet. Planetary Health
                The Author(s). Published by Elsevier Ltd.
                2542-5196
                4 June 2018
                June 2018
                4 June 2018
                : 2
                : 6
                : e238-e239
                Affiliations
                [a ]Antimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa
                Article
                S2542-5196(18)30124-4
                10.1016/S2542-5196(18)30124-4
                7129022
                29880152
                cef4eb31-cb4b-4a31-ba90-35f70c341a41
                © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                Categories
                Article

                Comments

                Comment on this article